QuidelOrtho (QDEL)
(Delayed Data from NSDQ)
$44.85 USD
+0.73 (1.65%)
Updated Sep 11, 2024 03:59 PM ET
After-Market: $45.07 +0.22 (0.49%) 5:10 PM ET
3-Hold of 5 3
A Value F Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$44.85 USD
+0.73 (1.65%)
Updated Sep 11, 2024 03:59 PM ET
After-Market: $45.07 +0.22 (0.49%) 5:10 PM ET
3-Hold of 5 3
A Value F Growth F Momentum D VGM
Zacks News
Bull of the Day: Meridian Bioscience (VIVO)
by Kevin Cook
Small-cap diagnostics player will grow sales 20%+ to over $310 million on COVID-19 testing and its mutations
Encompass Health (EHC) Forms JV to Boost Presence in Illinois
by Zacks Equity Research
Encompass Health (EHC) forms JV with UnityPoint Health - Trinity for constructing an inpatient rehabilitation hospital in Illinois to provide better health services in the state.
Top Ranked Momentum Stocks to Buy for January 7th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 7th.
Is Quidel (QDEL) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (QDEL) Outperforming Other Medical Stocks This Year?
Top Ranked Momentum Stocks to Buy for January 5th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 5th.
Allscripts (MDRX) Completes Sale of CarePort Health Business
by Zacks Equity Research
Allscripts' (MDRX) agreement with WellSky empowers providers with efficient care transitions and better patient health outcomes.
4 Top Momentum Stocks Powered by Driehaus Strategy
by Nitish Marwah
Investors with a high-risk appetite might give the Driehaus strategy a thought to boost their returns.
Maximize Your Portfolio Returns With Momentum Anomaly Stocks
by Zacks Equity Research
Shopify (SHOP), Trade Desk (TTD), Williams-Sonoma (WSM) and Quidel (QDEL) are currently witnessing a short-term pullback in price. So make sure you're taking full advantage of it.
Medtronic (MDT) MITG Shows Fast Recovery Amid COVID-19 Woes
by Zacks Equity Research
Medtronic (MDT) expects fiscal third-quarter MITG growth to be in the low single digits.
Quidel (QDEL) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Quidel (QDEL) closed at $197.49 in the latest trading session, marking a -1.26% move from the prior day.
Here's Why Hold Strategy is Apt for Magellan (MGLN) Stock
by Zacks Equity Research
Magellan Health (MGLN) has been benefiting from persistent tie-ups for offering enhanced behavioral health solutions and prudent capital deployment measures.
4 MedTech Stocks Up More Than 100% in 2020 With Room to Run
by Urmimala Biswas
We discuss four MedTech stocks, CDNA, FLGT, OMI and QDEL that more than doubled in 2020, and are poised to maintain market beating momentum in 2021 on strong fundamentals.
Ensign Group (ENSG) Rewards Shareholders With Dividend Hike
by Zacks Equity Research
Ensign Group's (ENSG) latest dividend hike indicates strong financial standing and continuous focus on boosting shareholders' value.
The Zacks Analyst Blog Highlights: Quidel, Halozyme Therapeutics, Teladoc Health, Acceleron Pharma and BioCryst Pharmaceuticals
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Quidel, Halozyme Therapeutics, Teladoc Health, Acceleron Pharma and BioCryst Pharmaceuticals
4 Healthcare Stocks to Take Care of in 2021 to Boost Portfolio
by Srijita Guha
Based on strong fundamentals, here we talk about four healthcare stocks to keep in your watchlist for 2021.
With Vaccine Distribution, What Stocks Do I Buy?
by John Blank
A Forward Looking Market Can Be Beguiling.
5 Healthcare Stocks That Fared Well in 2020 Amid the Pandemic
by Zacks Equity Research
We take a sneak peek into five healthcare stocks that have performed well in 2020 driven by their improved capabilities to cope with the COVID-19 crisis.
Quidel (QDEL) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Quidel (QDEL) closed at $196.43, marking a +1.7% move from the previous day.
Two Big Monetary Meetings: Global Week Ahead
by John Blank
The Bank of England (BoE) is not expected to alter its asset purchase target or its 0.1% Bank Rate. But obviously, the state of Brexit negotiations and the outcome into the New Year, and how markets take it, may be impactful to its assessments.
Bull of the Day: Quidel (QDEL)
by Kevin Cook
COVID and influenza A+B tests have launched sales and profit estimates triple-digits into 2021
Acadia Healthcare (ACHC) Forms JV to Boost Service in Detroit Area
by Zacks Equity Research
Acadia Healthcare (ACHC) partners with Henry Ford Health System for offering improved mental health services in Detroit and neighboring counties.
4 Top-Ranked MedTech Stocks to Bet on Heading Into 2021
by Trina Mukherjee
Grab these four top stocks that have shown tremendous promise despite market volatility due to the pandemic and have the potential to continue their bull run in 2021.
Alpine (ALPN) Looks Good: Stock Adds 7.8% in Session
by Zacks Equity Research
Alpine (ALPN) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.
Ensign Group (ENSG) Bolsters Presence in Texas With Buyout
by Zacks Equity Research
Ensign Group (ENSG) acquires a skilled nursing facility in Texas, which further adds stimulus to the company's acquisition spree.
Chembio Diagnostics (CEMI) Surges: Stock Moves 8.5% Higher
by Zacks Equity Research
Chembio Diagnostics (CEMI) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.